ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors.

被引：0
|
作者：
Ghazaly, Essam Ahmed
Joel, Simon
Gribben, John G.
Mohammad, Tariq
Emiloju, Oluwadunni
Stavraka, Chara
Hopkins, Tom
Gabra, Hani
Wasan, Harpreet
Habib, Nagy A.
Leonard, Robert C. F.
McGuigan, Christopher
Slusarczyk, Magdalena
Blagden, Sarah Patricia
机构：
[1] Queen Mary Univ London, Barts Canc Inst, London, England
[2] Univ London Imperial Coll Sci Technol & Med, NIHR Wellcome Trust Imperial Clin Res Facil, London, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London, England
[4] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2576
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase I/II, two-part, multicenter, first-in-human study of DS-7300a in patients with advanced solid malignant tumors.
    Bendell, Johanna C.
    Doi, Toshihiko
    Patel, Manish R.
    Piha-Paul, Sarina Anne
    Sen, Shiraj
    Shimizu, Toshio
    Cheng, Ben
    Mekan, Sabeen F.
    Myobatake, Yusuke
    Okuda, Yasuyuki
    Serbest, Gul
    Johnson, Melissa Lynne
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] A first-in-human phase I/Ib study of receptor tyrosine kinase (RTK) inhibitor, MGCD516, in patients with advanced solid tumors.
    Schwartz, Gary K.
    Adkins, Douglas
    Heist, Rebecca Suk
    Abbott, Maura
    Barber, Stephanie L.
    Chao, Richard C.
    Neuteboom, Saskia T. C.
    Chen, Isan
    Christensen, James
    Bauer, Todd Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] First-in-human Phase I dose-escalation study of a MET/AXL/FGFR inhibitor, S 49076, in patients with advanced solid tumors.
    Hollebecque, Antoine
    Soria, Jean-Charles
    Bahleda, Ratislav
    Lopez-Busto, Natividad
    Jacquet-Bescond, Anne
    Burbridge, Mike F.
    Valerie, Cattan
    Pauly, Jeanne
    Herranz, Maria
    Azaro, Analia
    Depil, Stephane
    Rodon, Jordi
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [34] First-in-human phase I study of JPH203, L-type amino acids transporter 1 inhibitor, in patients with advanced solid tumors.
    Okano, Naohiro
    Kawai, Kirio
    Kobayashi, Takaaki
    Nagashima, Fumio
    Endou, Hitoshi
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] First-in-human phase I study of the antiangiogenic vaccine (OTS11101) targeting VEGFR-1 in patients with solid tumors.
    Hayashi, H.
    Kurata, T.
    Fujisaka, Y.
    Satoh, T.
    Takeda, M.
    Miyazaki, M.
    Okabe, T.
    Kiyota, H.
    Tanaka, K.
    Tsunoda, T.
    Nakagawa, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] A first-in-human, phase I safety and pharmacokinetic study of genz-644282, a non-camptothecin topoisomerase I inhibitor, in patients with advanced solid tumors.
    Han, Hyo S.
    Tan, Antoinette R.
    Weiss, Glen J.
    Sullivan, Daniel
    Strosberg, Jonathan R.
    Collins, Sara
    Moss, Rebecca Anne
    Wu, Jingyang
    Ewesuedo, Reginald
    LoRusso, Patricia
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
    Teixeira, Luis
    Medioni, Jacques
    Garibal, Julie
    Adotevi, Olivier
    Doucet, Ludovic
    Durey, Marie-Agnes Dragon
    Ghrieb, Zineb
    Kiladjian, Jean-Jacques
    Brizard, Mara
    Laheurte, Caroline
    Wehbe, Maria
    Pliquet, Elodie
    Escande, Marie
    Defrance, Remy
    Culine, Stephane
    Oudard, Stephane
    Wain-Hobson, Simon
    Doppler, Valerie
    Huet, Thierry
    Langlade-Demoyen, Pierre
    CLINICAL CANCER RESEARCH, 2020, 26 (03) : 588 - 597
  • [38] A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
    Hong, David S.
    Kurzrock, Razelle
    Supko, Jeffrey G.
    He, Xiaoying
    Naing, Aung
    Wheler, Jennifer
    Lawrence, Donald
    Eder, Joseph Paul
    Meyer, Colin J.
    Ferguson, Deborah A.
    Mier, James
    Konopleva, Marina
    Konoplev, Sergej
    Andreeff, Michael
    Kufe, Donald
    Lazarus, Hillard
    Shapiro, Geoffrey I.
    Dezube, Bruce J.
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3396 - 3406
  • [39] First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors
    Keedy, Vicki L.
    Lenz, Heinz-Josef
    Saltz, Leonard
    Whisenant, Jennifer G.
    Berlin, Jordan D.
    Camacho, Luis H.
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 860 - 868
  • [40] First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors
    Vicki L. Keedy
    Heinz-Josef Lenz
    Leonard Saltz
    Jennifer G. Whisenant
    Jordan D. Berlin
    Luis H. Camacho
    Investigational New Drugs, 2018, 36 : 860 - 868
12345